N-acyl-N-naphthoylglycines as aldose reductase inhibitors

Details N-acyl-N-naphthoylglycines as aldose reductase inhibitors N-acyl-N-naphthoylglycines as aldose reductase inhibitors

1987-12-23

1989-04-11

Shippen, Michael L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

560 28, C07C125065, A61K 3127

Patent

active

048207276

ABSTRACT:
Disclosed herein are N-acyl-N-naphthoylglycines and methods of their preparation. The N-acyl-N-naphthoylglycines are novel aldose reductase inhibitors useful for the treatment or prevention of diabetic complications.

REFERENCES:
patent: 4391816 (1983-07-01), Sestani
patent: 4391825 (1983-07-01), Bellini
patent: 4439617 (1984-03-01), Sestani
patent: 4447452 (1984-05-01), Sestani
patent: 4568693 (1986-02-01), Sestani
patent: 4672058 (1987-06-01), Bellini
patent: 4672059 (1987-06-01), Sestani
Y. Mitin et al., CA 70: 68721m.
A. Bates et al., Helv. Chim. Acta, 58 (3), 688 (1975).

Affiliated with

Also associated with

Rating

N-acyl-N-naphthoylglycines as aldose reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-acyl-N-naphthoylglycines as aldose reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-acyl-N-naphthoylglycines as aldose reductase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-667554